A Revolution in Neurological Imaging
This article was originally published in Start Up
Executive Summary
Can brain imaging do for neurology what the human genome project is doing for therapeutics and diagnostics? Thanks in part to new imaging technologies, research on how the brain works is flourishing. But because treatments lag diagnostics, the commercialopportunities are unclear. So far, the biggest opportunities for the capital equipment makers which dominate the imaging industry seem to be in developing upgrades to drive continued demand for existing scanners.
You may also be interested in...
Imaging in its Heyday: Clinical Applications (Part II)
As scientific innovation in molecular imaging explodes, experts believe the big payoff will be in clinical, rather than research, applications. But absent validating clinical data, businesses remain hesitant to jump into the field.
Imaging in its Heyday: Research Applications (Part 1)
Biomolecular imaging is upgrading diagnostic imaging's stodgy reputation as scientists increasingly use it to improve both pharmaceutical research and clinical care. Part I of a two-part series explores researchers' excitement about biomolecular imaging's potential to improve the drug development process. Many companies see research applications as a way to prime the marketplace for clinical applications. But venture capitalists think research is a limited opportunity.
Making The Most Of ACOs: How Biopharma Is Adapting To New Customer Segment
ACOs have been one of the most hyped innovations in the US health care sector this decade. The buzz may be overdone, but ACOs are now established as a different—and confusing—new customer segment for pharma. How is industry adjusting?